CNBX Pharmaceutical (CNBX) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 81 220 sessions, November 5, 2025 to November 5, 2026
- Largest daily move
- +200% close of April 20, 2026
- 1-year change
- -75% closing prices, November 5, 2025 to November 5, 2026
- 1-month change
- +0% closing prices, October 5, 2026 to November 5, 2026
Company Description
CNBX Pharmaceutical (OTC: CNBX) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $160.6K.
CNBX has declined 75.0% over the past year. The last closing price was $0.0001.
For FY2025, CNBX Pharmaceutical reported revenue of $0 and diluted earnings per share of $0.00.
This page collects what Stock Titan holds for CNBX, including price data, latest news, SEC filings, financial highlights, and short interest trends.
Stock Performance
CNBX Pharmaceutical (CNBX) closed at $0.0001 on November 5, 2026. Over the past 12 months, the price has lost 75.0%.
CNBX Metrics & Rankings
Price returns through November 5, 2026. Month and year figures include the first trading day. Ranking links may use different dates.
Latest News
CNBX Pharmaceutical has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 2 with negative movement. Key topics include acquisition, clinical trial. View all CNBX news →
SEC Filings
CNBX Pharmaceutical has filed 10 recent SEC filings, including 4 Form SCHEDULE 13G/A, 3 Form 10-Q, 2 Form 8-K, 1 Form 10-K. The most recent filing was submitted on . SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all CNBX SEC filings →
Financial Highlights
Upcoming Events
Short Interest History
Short interest in CNBX Pharmaceutical (CNBX) currently stands at 1 shares, down 100.0% from the previous reporting period. Since November 2025, short interest has decreased by 99.9%.
Days to Cover History
Days to cover for CNBX Pharmaceutical (CNBX) currently stands at 1.0 days. The ratio is the reported short interest divided by the average daily trading volume.
CNBX Company Profile & Sector Positioning
CNBX Pharmaceutical (CNBX) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing CNBX often look at related companies in the same sector, including Regen BioPharma Inc (RGBP), Marijuana Inc (MAJI), Appili Therapeutics Inc (APLIF), Regenerative Medical Tech (RMTG), and Orgenesis Inc (ORGS). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CNBX's relative position within its industry.